Milestone Scientific Expanded Commercial Infrastructure
The medical company has bolstered its sales team and reimbursement support for its CompuFlo epidural technology.
Updated on Sept. 29, 2026 in Public Companies
Live Poll
Do you trust that new medical technology business expansions lead to better care for your household?
Milestone Scientific has scaled its commercial operations and physician education efforts to drive adoption of its CompuFlo medical technology. The company also announced expanded reimbursement support for procedures using the platform.
Why it matters
These initiatives are designed to increase physician adoption and drive recurring revenue from disposables. The company aims to establish a repeatable model for geographic expansion across the United States.
Medicare provides roughly $325 per procedure under CPT Category III code 0777T, while Milestone Scientific has grown its workforce to three dedicated medical sales professionals and 15 consultants.
The players
Milestone Scientific
This is a publicly traded medical device company headquartered in Roseland, N.J., that develops the CompuFlo pressure-sensing technology.
Avania Medical LLC
This organization acts as a strategic partner to Milestone Scientific, providing specialized reimbursement and market-access support.
The details
Milestone Scientific is integrating direct sales resources with reimbursement support provided by Avania Medical LLC to navigate current payment landscapes. A study from the University of Texas Medical Branch indicated that CompuFlo-guided access resulted in a 91% reduction in the adjusted odds of composite complications for 79 patients.
Timeline
The company reported its Advisor Program feedback data through September 2026.
Market Landscape
Milestone Scientific is positioning its CompuFlo technology to capture market share within the competitive field of medical instrumentation. Its strategy to utilize the CPT Category III code 0777T reimbursement framework signals a broader effort to secure long-term commercial viability against legacy alternatives.
The expansion of reimbursement support may increase accessibility to CompuFlo-guided procedures for Medicare patients at participating academic medical centers. Increased physician adoption could potentially lower the incidence of procedure-related complications for patients.
The takeaway
Milestone Scientific is attempting to standardize its market presence by combining clinical data with active reimbursement navigation. The company’s focus remains on proving the efficacy of its technology to medical institutions while streamlining the billing process for providers.
Further reading
For more on the financial trajectory of the medical sector, visit Public Companies.
More information
Review recent updates and clinical outcomes on the Company official website.
Source note: This article includes information reported by The Manila times.
Live Poll
Do you trust that new medical technology business expansions lead to better care for your household?
